secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cencora, Inc. (COR)
CIK:        0001140859
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0001104659-24-115578
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cencora to acquire Retina Consultants of America for $4.6B, ~85% ownership, accretive $0.35
--------------------------------------------------------------------------------

- Enterprise value of $4.6B cash; expected cash outlay ~$4.3B after physician/management rollover and fees.
- Cencora will hold ~85% ownership; up to $500M contingent consideration in FY2027-2028 tied to predefined objectives.
- Transaction expected ~$0.35 accretive to adjusted diluted EPS in first 12 months post-close.
- RCA operates nearly 300 retina specialists across 23 states, 2M+ annual visits, 40 clinical trial sites.
- Funding via cash on hand and new debt; $3.3B bridge financing obtained; fiscal 2025 guidance excludes deal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1140859/000110465924115578/0001104659-24-115578-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1140859/000110465924115578/tm2427560d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-115578

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer